Open official notice

Bromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only

Official notice

14 Sept 2016

RecallScope risk estimate:MediumFDA

An official FDA notice concerns Bromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only. Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches. Published 2016-09-14.

What to do now

This recall has been terminated. See the official FDA notice for the latest status.

Units affected

14,808

Recall number

D-1491-2016

Official notice

2016-09-14

The hazard

Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

MP993

Event Ids

74233

Recall Numbers

D-1491-2016

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Bromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only, Manufactured by: Cadila Healthcare ltd., Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-110-06

Units affected

14,808

Hazard

Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Zydus Pharmaceuticals USA Inc

Phone

Not provided

Brand: Zydus Pharmaceuticals. Contact: Zydus Pharmaceuticals USA Inc.

Source & status

Source

Tier

official

Category

Health

Official classification

Class II

Recall details

Recall number

D-1491-2016

Event ID

74233

Units affected

14,808

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 14 Sept 2016. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button